Transcept Pharmaceuticals Inc (NASDAQ:TSPT)
Industry: Healthcare

OFF LIST - 564 consecutive market days: OFF LIST as of 04/26/2012 Through 07/23/2014

Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of proprietary products that address therapeutic needs in the field of neuroscience. Its principal product comprises Intermezzo sublingual tablet C-IV, a sublingual formulation of zolpidem for the treatment of insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep. The company has a collaboration agreement with Purdue Pharmaceutical Products, L.P. for the commercialization of Intermezzo in the United States, as well as granted Purdue Pharmaceutical Products, L.P. the right to negotiate for the commercialization of Intermezzo in Mexico and Canada. Transcept Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Point Richmond, California.

Current Quote*
Last: $2.280
Change: 0.060
Book: $0.800
Volume: 69,103

As Of: 07/24 20:05 PDT ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol TSPT

Graphs for TSPT


3 Month Graph


6 Month Graph


1 Year Graph